We'd all like to see a cure for type 2 diabetes on the horizen,
but so far, it's not in the works. All we can hope for at the
moment is improved gizmos and gadgets that might make our lives
a little easier but won't cure the underlying problem, or new
approaches to treating patients that might improve our care.
Some of the proposals for new approaches to both obesity and
diabetes at the recent Cleveland Clinic Innovation Summit were
as follows: Tailoring, or developing biomarkers that would show
which subpopulations or individual patients would benefit from a
specific treatment and which would not. As patients, we
understand the concept of YMMV (your mileage may vary). Some
physicians who follow evidence-based medicine that is based on
average responses don't seem as willing to tailor the results to
the individual and probably won't until there's some way of
measuring individual risks. Focusing on comorbidities of obesity
rather than weight itself. If someone is overweight but
otherwise active and healthy, th